🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study seeks to estimate the potential efficacy of the study treatment,...
Status
Unknown
Location
Ascension Providence Rochester Hospital
Start Date
2021-05-19
Trial ID
NCT04713371
This phase III trial compares the effectiveness of pembrolizumab and sacitu...
Status
Recruiting
Location
Cancer Center at Saint Joseph's
Start Date
2025-12-02
Trial ID
NCT06524544
This study is being done to find out if SEA-CD40 is safe and effective when...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2015-02-28
Trial ID
NCT02376699
Treatments Being Tested
This is a Phase 1/2a, open-label, study to evaluate the safety and prelimin...
Status
Recruiting
Location
Banner MD Anderson Cancer Center
Start Date
2020-09-17
Trial ID
NCT04370587
Treatments Being Tested
The goal of this investigational, multicenter, open-label randomized, two-s...
Status
Not Yet Recruiting
Location
Institut Sainte Catherine
Start Date
2025-09
Trial ID
NCT06646445
Treatments Being Tested
A randomized phase II clinical trial of SBRT and systemic pembrolizumab wit...
Status
Unknown
Location
Universitair Ziekenhuis Brussel
Start Date
2020-09-22
Trial ID
NCT04571632
This phase I trial evaluates the safety and effectiveness of in situ immuno...
Status
Active Not Recruiting
Location
Los Angeles General Medical Center
Start Date
2023-01-09
Trial ID
NCT04616248
The study will assess the safety, tolerability, PK and efficacy of differen...
Status
Completed
Location
Jules Bordet Institute
Start Date
2013-11
Trial ID
NCT01986426
Treatments Being Tested
This is a phase 3, randomized, double-blind study of adjuvant calderasib pl...
Status
Recruiting
Location
Instituto Alexander Fleming ( Site 0310)
Start Date
2026-03-18
Trial ID
NCT07431827
Treatments Being Tested
Maintainance therapy in patients with unresectable stage III, NSCLC Stage I...
Status
Unknown
Location
CRO Aviano
Start Date
2018-01-01
Trial ID
NCT03379441
Treatments Being Tested